S. Grant

A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.

I. Stiell, B. Rowe, J. Lee, 2004, Journal of the American College of Cardiology.

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

H. Heidbuchel, D. Atar, J. Le Heuzey, 2021, BMC Medicine.

Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial

Joanna M. Wardlaw, Eleni Sakka, Geoff Cohen, 2015, Stroke.

P Cardiac Rhythm Disturbances Randomized , Controlled Trial of SD 1235 , a Novel AntiArrhythmic Agent , n the Treatment of Recent Onset Atrial Fibrillation

I. Stiell, B. Rowe, J. Lee, 2016 .